Literature DB >> 9463343

Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response.

G A Poland1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9463343      PMCID： PMC1376909          DOI： 10.1086/301736

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  37 in total

1.  Measles antibody: reevaluation of protective titers.

Authors:  R T Chen; L E Markowitz; P Albrecht; J A Stewart; L M Mofenson; S R Preblud; W A Orenstein
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

Review 2.  Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?

Authors:  E O Long; S Jacobson
Journal:  Immunol Today       Date:  1989-02

3.  Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus.

Authors:  M S Hayney; G A Poland; P Dimanlig; D J Schaid; R M Jacobson; J J Lipsky
Journal:  Vaccine       Date:  1997-01       Impact factor: 3.641

4.  Epidemiology of infectious disease: the example of measles.

Authors:  F L Black; F Pinheiro; W J Hierholzer; R V Lee
Journal:  Ciba Found Symp       Date:  1977

5.  HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells.

Authors:  S Jacobson; R P Sekaly; C L Jacobson; H F McFarland; E O Long
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

6.  The role of secondary vaccine failures in measles outbreaks.

Authors:  R G Mathias; W G Meekison; T A Arcand; M T Schechter
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

7.  Recognition of intracellular measles virus antigens by HLA class II restricted measles virus-specific cytotoxic T lymphocytes.

Authors:  S Jacobson; R P Sekaly; W J Bellini; C L Johnson; H F McFarland; E O Long
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

8.  Evidence for heterosis in the HLA system.

Authors:  F L Black; F M Salzano
Journal:  Am J Hum Genet       Date:  1981-11       Impact factor: 11.025

9.  Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens.

Authors:  S Jacobson; J R Richert; W E Biddison; A Satinsky; R J Hartzman; H F McFarland
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

10.  Class II MHC molecules can use the endogenous pathway of antigen presentation.

Authors:  J G Nuchtern; W E Biddison; R D Klausner
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962
View more
  14 in total

1.  Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

Authors:  E Gonzalez; R Dhanda; M Bamshad; S Mummidi; R Geevarghese; G Catano; S A Anderson; E A Walter; K T Stephan; M F Hammer; A Mangano; L Sen; R A Clark; S S Ahuja; M J Dolan; S K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Genetic determinants of immune-response to a polysaccharide vaccine for typhoid.

Authors:  Partha P Majumder; Herman F Staats; Neeta Sarkar-Roy; Binuja Varma; Trina Ghosh; Sujit Maiti; K Narayanasamy; Carol C Whisnant; James L Stephenson; Diane K Wagener
Journal:  Hugo J       Date:  2010-03-11

3.  Toxicogenomic profiles in relation to maternal immunotoxic exposure and immune functionality in newborns.

Authors:  Kevin Hochstenbach; D M van Leeuwen; H Gmuender; R W Gottschalk; S B Stølevik; U C Nygaard; M Løvik; B Granum; E Namork; H M Meltzer; J C Kleinjans; J H M van Delft; Henk van Loveren
Journal:  Toxicol Sci       Date:  2012-06-27       Impact factor: 4.849

4.  Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses.

Authors:  Inna G Ovsyannikova; Jenna E Ryan; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Immunogenetics       Date:  2005-12-06       Impact factor: 2.846

5.  Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations.

Authors:  Berran Yucesoy; Yerkebulan Talzhanov; Victor J Johnson; Nevin W Wilson; Raymond E Biagini; Wei Wang; Bonnie Frye; David N Weissman; Dori R Germolec; Michael I Luster; Michael M Barmada
Journal:  Vaccine       Date:  2013-09-26       Impact factor: 3.641

6.  Genomic correlates of variability in immune response to an oral cholera vaccine.

Authors:  Partha P Majumder; Neeta Sarkar-Roy; Herman Staats; T Ramamurthy; Sujit Maiti; Goutam Chowdhury; Carol C Whisnant; K Narayanasamy; Diane K Wagener
Journal:  Eur J Hum Genet       Date:  2012-12-19       Impact factor: 4.246

Review 7.  Application of pharmacogenomics to vaccines.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Pharmacogenomics       Date:  2009-05       Impact factor: 2.533

Review 8.  Vaccine immunogenetics: bedside to bench to population.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Vaccine       Date:  2008-07-01       Impact factor: 3.641

Review 9.  Personalized vaccines: the emerging field of vaccinomics.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Expert Opin Biol Ther       Date:  2008-11       Impact factor: 4.388

Review 10.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.